Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

RadNet typically reports earnings before the market opens, meaning Day 0 captures the first full trading session where investors react to results, while Day +1 reflects follow-through sentiment.

RadNet's post-earnings price action has been characterized by significant volatility, with an average absolute Day 0 move of 7.58% and an average Day 0 range of 12.65%. The most recent earnings release (Q2 2026, reported August 10) saw the stock surge 6.76% on Day 0 with an intraday range of 12.51%, followed by a modest pullback of 1.22% on Day +1. The prior quarter (Q1 2026, reported May 11) saw a more muted Day 0 decline of 3.94% with a 13.30% range, followed by minimal Day +1 movement.

The largest single-day reaction came in August 2025, when the stock jumped 16.19% on Day 0 following a strong beat, with continued momentum of 2.58% on Day +1. Conversely, the March 2026 report saw a 7.75% Day 0 gain followed by a 3.51% Day +1 reversal, illustrating how initial enthusiasm can quickly fade.

On average, Day +1 moves have been more subdued at 2.08% with a range of 5.88%, suggesting that most of the price discovery occurs in the immediate reaction to results. Investors should expect a high-single-digit percentage move on the day of the report, with the direction heavily dependent on whether the company beats or misses estimates and, critically, on the tone of management's guidance and commentary around Digital Health progress.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 10.87% (approximately $8.25) for the November 20 expiration, which is notably higher than the historical average Day 0 move of 7.58% but lower than the average Day 0 range of 12.65%. This suggests options traders are anticipating above-average volatility but not an extreme outlier event. The expected move is roughly in line with the most volatile recent reactions, such as the 12.51% Day 0 range in Q2 2026 and the 15.39% range in Q3 2025, indicating that the market is bracing for a potentially significant swing in either direction depending on results and guidance.

Part 3: What Analysts Are Saying

Current Analyst Consensus

RadNet enjoys strong bullish sentiment from the analyst community, with a consensus rating of 5.00 (Strong Buy) based on 8 Strong Buy ratings and zero Hold or Sell ratings. This represents an improved sentiment trend from one month ago, when the consensus stood at 4.75 with 7 Strong Buys and 1 Hold. The upgrade reflects growing confidence in the company's execution and growth trajectory.

The average price target of $91.38 implies 20% upside from the current price of $76.00, with a range spanning from a low of $79.00 to a high of $100.00. This relatively tight range—spanning just $21—suggests analysts are largely aligned on the company's valuation, with no extreme outliers betting on either wild success or failure.

Ratings Breakdown and Recent Changes

The current breakdown shows 8 Strong Buy ratings and no Hold or Sell ratings, a notably bullish configuration. One month ago, the mix included 7 Strong Buys and 1 Hold, indicating that at least one analyst has upgraded their stance in recent weeks. The absence of any bearish ratings is striking and reflects the Street's conviction that RadNet's dual growth engines—core imaging center expansion and Digital Health commercialization—can drive sustained outperformance.

Sentiment Shift and Price Target Implications

The improved sentiment trend is supported by recent analyst actions, including Truist Financial lifting its price target to $94 and Raymond James reiterating a Strong Buy rating. Analysts have cited several catalysts: raised 2026 guidance following Q2's beat, FDA clearance for the DeepHealth breast ultrasound AI solution, strong advanced imaging volume trends, and successful integration of recent acquisitions. The consensus price target of $91.38 implies that analysts see the current valuation as attractive, with the stock trading at a meaningful discount to fair value despite its year-to-date gains.

Part 4: Technical Picture

RadNet's technical setup heading into earnings reflects strong momentum across multiple timeframes. The Barchart Technical Opinion currently stands at 88% Buy, up sharply from 80% Buy one week ago and 40% Buy one month ago, signaling accelerating bullish sentiment.

Timeframe Analysis:

• Short-term (50% Buy): Moderate buy signal suggests near-term momentum is positive but not extreme, leaving room for further upside if earnings impress
• Medium-term (100% Buy): Strong buy signal indicates robust intermediate-term trend strength, with the stock well-positioned technically for a sustained move higher
• Long-term (100% Buy): Strong buy signal reflects solid longer-term trend structure, suggesting the broader uptrend remains intact

Trend Characteristics: The technical environment is characterized by Strong strength and Average direction, indicating that while the trend is powerful, it is not yet overextended or parabolic, which could provide a more stable foundation for a post-earnings move.

The stock is trading at $76.00, positioned above its 10-day ($74.48), 20-day ($72.21), 50-day ($72.57), 100-day ($69.57), and 200-day ($65.25) moving averages, though below the 5-day moving average ($76.11). This configuration—above all major moving averages except the very short-term 5-day—suggests a healthy uptrend with recent consolidation near current levels. The stock has built a solid technical base over the past several months, with each successive moving average providing support at progressively lower levels. The overall technical setup is supportive heading into earnings, with the stock in a clear uptrend but not overextended, potentially allowing for a constructive reaction if results and guidance meet or exceed expectations. However, the slight pullback below the 5-day moving average suggests some near-term caution, and a miss or disappointing guidance could quickly test support at the 10-day moving average around $74.50.